Nalfon (Xspire Pharma)
Welcome to the PulseAid listing for the Nalfon drug offered from Xspire Pharma. This Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Xspire Pharma |
NON-PROPRIETARY NAME: | fenoprofen calcium |
SUBSTANCE NAME: | FENOPROFEN CALCIUM |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2012-08-27 |
END MARKETING DATE: | 0000-00-00 |
Nalfon HUMAN PRESCRIPTION DRUG Details:
Item Description | Nalfon from Xspire Pharma |
LABELER NAME: | Xspire Pharma |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 400(mg/1) |
START MARKETING DATE: | 2012-08-27 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 42195-308_3336dc98-5777-61a3-e054-00144ff8d46c |
PRODUCT NDC: | 42195-308 |
APPLICATION NUMBER: | NDA017604 |
Other FENOPROFEN CALCIUM Pharmaceutical Manufacturers / Labelers: